Wird geladen...
Treating Parkinson’s disease by astrocyte reprogramming: Progress and challenges
Parkinson’s disease (PD), the second most prevalent neurodegenerative disorder, is typified by both motor and nonmotor symptoms. The current medications provide symptomatic relief but do not stimulate the production of new dopaminergic neurons in the substantia nigra. Astrocyte reprogramming has rec...
Gespeichert in:
| Veröffentlicht in: | Sci Adv |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Association for the Advancement of Science
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8221613/ https://ncbi.nlm.nih.gov/pubmed/34162545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.abg3198 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|